NYSE:RCUSBiotechs
Why Arcus Biosciences (RCUS) Is Getting Attention Today
Arcus Biosciences (RCUS) continues to attract attention after recent share price moves, with the stock closing at US$30.12. Investors are weighing its clinical-stage cancer pipeline and its latest trading performance.
See our latest analysis for Arcus Biosciences.
The recent move to US$30.12 comes after a mixed near term patch, with the 1-day share price return slightly down, but a 90-day share price return of 24.82% and a 1-year total shareholder return of 196.75% point to strong underlying...